Community pharmacist prescribing: $4.4 billion in savings

A pharmacist intervention for patients at high risk of cardiovascular disease both improves patient outcomes and saves money, according to new research Pharmacist researchers from Canada have developed a model that quantifies the savings that a community pharmacist intervention for reducing cardiovascular risk could achieve. The RxEACH study is the largest randomised controlled trial conducted

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous The week in review
Next ‘Fear-mongering, pure and simple.’